A mutation found in NF2 (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor) on Chromosome 22 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated?
Pathogenic; Neurofibromatosis, type 2